US Stock MarketDetailed Quotes

SHANGHAI PHARMACEU (SHPMY)

Watchlist
  • 7.600
  • 0.0000.00%
15min DelayClose Mar 4 10:16 ET
5.64BMarket Cap6.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SHANGHAI PHARMACEU (SHPMY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
3.03%283.58B
4.40%68.51B
4.65%73.48B
2.27%70.83B
0.87%70.76B
5.75%275.25B
4.52%65.62B
8.16%70.22B
4.36%69.26B
5.93%70.15B
Operating revenue
3.03%283.58B
4.40%68.51B
4.65%73.48B
2.27%70.83B
0.87%70.76B
5.75%275.25B
4.52%65.62B
8.16%70.22B
4.36%69.26B
5.93%70.15B
Cost of revenue
3.49%253.16B
4.03%60.51B
4.41%65.99B
3.33%63.15B
2.22%63.51B
6.84%244.62B
4.96%58.17B
8.95%63.21B
5.49%61.12B
7.87%62.12B
Gross profit
-0.70%30.42B
7.27%8B
6.82%7.49B
-5.70%7.68B
-9.61%7.26B
-2.22%30.63B
1.21%7.45B
1.53%7.01B
-3.37%8.14B
-7.03%8.03B
Operating expense
0.91%21.13B
8.96%5.94B
13.14%5.31B
-5.65%5.17B
-11.34%4.72B
-3.77%20.94B
-1.19%5.45B
-0.60%4.69B
-4.04%5.48B
-8.53%5.33B
Selling and administrative expenses
-3.29%8.64B
-3.41%-4.85B
5.19%9.31B
3.63%86.44M
-12.75%4.09B
-13.65%8.93B
-8.58%-4.69B
1.62%8.86B
-87.33%83.41M
-11.49%4.68B
-Selling and marketing expense
-1.10%7.28B
3.80%-2.03B
5.71%5.73B
7.74%823M
-16.11%2.76B
-16.74%7.37B
-30.18%-2.11B
3.50%5.42B
-42.02%763.86M
-15.86%3.29B
-General and administrative expense
-13.59%1.35B
-9.33%-2.81B
4.37%3.58B
-8.25%-736.57M
-4.81%1.32B
4.57%1.57B
4.45%-2.57B
-1.22%3.43B
-3.26%-680.45M
0.90%1.39B
Research and development costs
-2.27%2.34B
5.94%824.53M
8.88%556.53M
-23.47%461.93M
-0.88%497.02M
8.64%2.39B
5.75%778.29M
15.71%511.12M
24.29%603.57M
-7.26%501.45M
-Depreciation and amortization
21.41%1.58B
----
----
----
----
11.21%1.3B
----
----
----
----
Other operating expenses
6.97%915.03M
7.15%279.06M
26.61%176.43M
3.81%256.51M
-2.64%203.04M
3.64%855.41M
-5.97%260.45M
21.58%139.34M
2.52%247.08M
8.20%208.54M
Operating profit
-4.20%9.28B
2.70%2.06B
-5.98%2.18B
-5.80%2.51B
-6.21%2.53B
1.30%9.69B
8.34%2.01B
6.12%2.32B
-1.96%2.66B
-3.92%2.7B
Net non-operating interest income expense
4.39%-1.35B
10.66%-230.32M
13.29%-373.79M
-6.60%-366.36M
-0.08%-374.72M
6.02%-1.41B
24.80%-257.8M
-19.22%-431.09M
8.25%-343.67M
10.46%-374.43M
Non-operating interest income
-22.48%404.97M
-15.31%134.74M
-11.89%93.85M
-22.92%92.89M
-38.73%83.49M
13.11%522.39M
51.38%159.09M
-26.12%106.51M
16.14%120.5M
25.24%136.28M
Non-operating interest expense
-9.20%1.69B
-13.78%405.19M
-16.21%393.02M
-0.56%443.61M
-5.85%444.08M
-1.50%1.86B
10.92%469.94M
-5.97%469.02M
-5.18%446.1M
-4.13%471.67M
Total other finance cost
-11.53%64.26M
24.35%-40.13M
8.81%74.62M
-13.45%15.64M
-63.80%14.13M
-1.86%72.63M
-319.08%-53.05M
889.56%68.58M
129.69%18.07M
11.53%39.04M
Other net income (expense)
Special income (charges)
-120.07%-1.44B
39.62%-181.99M
-186.34%-460.06M
-873.12%-571.31M
-69.06%-222.75M
12.85%-652.57M
48.97%-301.43M
-517.86%-160.67M
-21.35%-58.71M
11.03%-131.76M
-Less:Impairment of capital assets
65.79%1.02B
-58.31%229.14M
1,243.90%379.33M
595.84%443.6M
-23.13%-33.52M
9.46%614.37M
-7.66%549.62M
-12.30%28.23M
137.76%63.75M
-126.50%-27.22M
-Less:Other special charges
16.39%-157.15M
106.98%2.94M
-1,743.48%-120.11M
-39.68%-40.89M
100.82%903.05K
-103.26%-187.97M
-448.19%-42.14M
78.87%-6.52M
43.67%-29.27M
-405.21%-110.04M
-Write off
154.11%574.71M
75.69%-50.09M
44.52%200.83M
595.79%168.6M
-5.07%255.37M
-19.22%226.16M
-1,144.74%-206.05M
449.11%138.96M
-91.00%24.23M
300.73%269.02M
Other non- operating income (expenses)
-1.30%-122.28M
13.19%-83.61M
-66.78%-25.87M
-75.56%-19.13M
213.51%6.33M
80.31%-120.71M
83.28%-96.32M
-22.46%-15.51M
57.43%-10.89M
54.93%2.02M
Income before tax
22.44%9.82B
10.62%1.52B
-18.94%1.48B
94.07%4.67B
-10.92%2.15B
13.69%8.02B
156.98%1.38B
-8.20%1.82B
17.80%2.41B
-3.02%2.42B
Income tax
32.38%2.85B
0.99%534.14M
22.57%485.91M
95.02%1.31B
-7.00%512.52M
13.89%2.15B
64.01%528.92M
-11.60%396.42M
16.54%673.53M
2.28%551.13M
Net income
18.80%6.97B
16.64%987.57M
-30.48%991.37M
93.71%3.35B
-12.08%1.64B
13.62%5.87B
297.89%846.71M
-7.21%1.43B
18.30%1.73B
-4.48%1.87B
Net income continuous Operations
18.80%6.97B
16.64%987.57M
-30.48%991.37M
93.71%3.35B
-12.08%1.64B
13.62%5.87B
297.89%846.71M
-7.21%1.43B
18.30%1.73B
-4.48%1.87B
Minority interest income
-5.19%1.25B
17.72%410.08M
-3.35%303.17M
-31.12%228.8M
-5.00%307.12M
-5.80%1.32B
44.21%348.36M
-10.33%313.67M
-10.66%332.16M
-25.75%323.29M
Net income attributable to the parent company
25.74%5.72B
15.88%577.49M
-38.13%688.2M
123.33%3.13B
-13.56%1.33B
20.82%4.55B
1,832.12%498.35M
-6.29%1.11B
28.15%1.4B
1.62%1.54B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
25.74%5.72B
15.88%577.49M
-38.13%688.2M
123.33%3.13B
-13.56%1.33B
20.82%4.55B
1,832.12%498.35M
-6.29%1.11B
28.15%1.4B
1.62%1.54B
Basic earnings per share
25.20%7.7
7.14%0.75
-36.67%0.95
127.03%4.2
-14.29%1.8
20.59%6.15
1,500.00%0.7
-6.25%1.5
23.33%1.85
2.44%2.1
Diluted earnings per share
25.20%7.7
7.14%0.75
-36.67%0.95
127.03%4.2
-14.29%1.8
20.59%6.15
1,500.00%0.7
-6.25%1.5
23.33%1.85
2.44%2.1
Dividend per share
-16.17%2.0437
50.08%0.5904
-28.91%1.4533
0
0
-18.83%2.4378
0.3934
-31.93%2.0444
0
0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 3.03%283.58B4.40%68.51B4.65%73.48B2.27%70.83B0.87%70.76B5.75%275.25B4.52%65.62B8.16%70.22B4.36%69.26B5.93%70.15B
Operating revenue 3.03%283.58B4.40%68.51B4.65%73.48B2.27%70.83B0.87%70.76B5.75%275.25B4.52%65.62B8.16%70.22B4.36%69.26B5.93%70.15B
Cost of revenue 3.49%253.16B4.03%60.51B4.41%65.99B3.33%63.15B2.22%63.51B6.84%244.62B4.96%58.17B8.95%63.21B5.49%61.12B7.87%62.12B
Gross profit -0.70%30.42B7.27%8B6.82%7.49B-5.70%7.68B-9.61%7.26B-2.22%30.63B1.21%7.45B1.53%7.01B-3.37%8.14B-7.03%8.03B
Operating expense 0.91%21.13B8.96%5.94B13.14%5.31B-5.65%5.17B-11.34%4.72B-3.77%20.94B-1.19%5.45B-0.60%4.69B-4.04%5.48B-8.53%5.33B
Selling and administrative expenses -3.29%8.64B-3.41%-4.85B5.19%9.31B3.63%86.44M-12.75%4.09B-13.65%8.93B-8.58%-4.69B1.62%8.86B-87.33%83.41M-11.49%4.68B
-Selling and marketing expense -1.10%7.28B3.80%-2.03B5.71%5.73B7.74%823M-16.11%2.76B-16.74%7.37B-30.18%-2.11B3.50%5.42B-42.02%763.86M-15.86%3.29B
-General and administrative expense -13.59%1.35B-9.33%-2.81B4.37%3.58B-8.25%-736.57M-4.81%1.32B4.57%1.57B4.45%-2.57B-1.22%3.43B-3.26%-680.45M0.90%1.39B
Research and development costs -2.27%2.34B5.94%824.53M8.88%556.53M-23.47%461.93M-0.88%497.02M8.64%2.39B5.75%778.29M15.71%511.12M24.29%603.57M-7.26%501.45M
-Depreciation and amortization 21.41%1.58B----------------11.21%1.3B----------------
Other operating expenses 6.97%915.03M7.15%279.06M26.61%176.43M3.81%256.51M-2.64%203.04M3.64%855.41M-5.97%260.45M21.58%139.34M2.52%247.08M8.20%208.54M
Operating profit -4.20%9.28B2.70%2.06B-5.98%2.18B-5.80%2.51B-6.21%2.53B1.30%9.69B8.34%2.01B6.12%2.32B-1.96%2.66B-3.92%2.7B
Net non-operating interest income expense 4.39%-1.35B10.66%-230.32M13.29%-373.79M-6.60%-366.36M-0.08%-374.72M6.02%-1.41B24.80%-257.8M-19.22%-431.09M8.25%-343.67M10.46%-374.43M
Non-operating interest income -22.48%404.97M-15.31%134.74M-11.89%93.85M-22.92%92.89M-38.73%83.49M13.11%522.39M51.38%159.09M-26.12%106.51M16.14%120.5M25.24%136.28M
Non-operating interest expense -9.20%1.69B-13.78%405.19M-16.21%393.02M-0.56%443.61M-5.85%444.08M-1.50%1.86B10.92%469.94M-5.97%469.02M-5.18%446.1M-4.13%471.67M
Total other finance cost -11.53%64.26M24.35%-40.13M8.81%74.62M-13.45%15.64M-63.80%14.13M-1.86%72.63M-319.08%-53.05M889.56%68.58M129.69%18.07M11.53%39.04M
Other net income (expense)
Special income (charges) -120.07%-1.44B39.62%-181.99M-186.34%-460.06M-873.12%-571.31M-69.06%-222.75M12.85%-652.57M48.97%-301.43M-517.86%-160.67M-21.35%-58.71M11.03%-131.76M
-Less:Impairment of capital assets 65.79%1.02B-58.31%229.14M1,243.90%379.33M595.84%443.6M-23.13%-33.52M9.46%614.37M-7.66%549.62M-12.30%28.23M137.76%63.75M-126.50%-27.22M
-Less:Other special charges 16.39%-157.15M106.98%2.94M-1,743.48%-120.11M-39.68%-40.89M100.82%903.05K-103.26%-187.97M-448.19%-42.14M78.87%-6.52M43.67%-29.27M-405.21%-110.04M
-Write off 154.11%574.71M75.69%-50.09M44.52%200.83M595.79%168.6M-5.07%255.37M-19.22%226.16M-1,144.74%-206.05M449.11%138.96M-91.00%24.23M300.73%269.02M
Other non- operating income (expenses) -1.30%-122.28M13.19%-83.61M-66.78%-25.87M-75.56%-19.13M213.51%6.33M80.31%-120.71M83.28%-96.32M-22.46%-15.51M57.43%-10.89M54.93%2.02M
Income before tax 22.44%9.82B10.62%1.52B-18.94%1.48B94.07%4.67B-10.92%2.15B13.69%8.02B156.98%1.38B-8.20%1.82B17.80%2.41B-3.02%2.42B
Income tax 32.38%2.85B0.99%534.14M22.57%485.91M95.02%1.31B-7.00%512.52M13.89%2.15B64.01%528.92M-11.60%396.42M16.54%673.53M2.28%551.13M
Net income 18.80%6.97B16.64%987.57M-30.48%991.37M93.71%3.35B-12.08%1.64B13.62%5.87B297.89%846.71M-7.21%1.43B18.30%1.73B-4.48%1.87B
Net income continuous Operations 18.80%6.97B16.64%987.57M-30.48%991.37M93.71%3.35B-12.08%1.64B13.62%5.87B297.89%846.71M-7.21%1.43B18.30%1.73B-4.48%1.87B
Minority interest income -5.19%1.25B17.72%410.08M-3.35%303.17M-31.12%228.8M-5.00%307.12M-5.80%1.32B44.21%348.36M-10.33%313.67M-10.66%332.16M-25.75%323.29M
Net income attributable to the parent company 25.74%5.72B15.88%577.49M-38.13%688.2M123.33%3.13B-13.56%1.33B20.82%4.55B1,832.12%498.35M-6.29%1.11B28.15%1.4B1.62%1.54B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 25.74%5.72B15.88%577.49M-38.13%688.2M123.33%3.13B-13.56%1.33B20.82%4.55B1,832.12%498.35M-6.29%1.11B28.15%1.4B1.62%1.54B
Basic earnings per share 25.20%7.77.14%0.75-36.67%0.95127.03%4.2-14.29%1.820.59%6.151,500.00%0.7-6.25%1.523.33%1.852.44%2.1
Diluted earnings per share 25.20%7.77.14%0.75-36.67%0.95127.03%4.2-14.29%1.820.59%6.151,500.00%0.7-6.25%1.523.33%1.852.44%2.1
Dividend per share -16.17%2.043750.08%0.5904-28.91%1.453300-18.83%2.43780.3934-31.93%2.044400
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -